189385-64-6

Basic information

• Product Name: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4R)-(9CI)
• Synonyms: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4R)-(9CI);(2R,4R)-4-hydroxypiperidine-2-carboxylic acid
• CAS NO: 189385-64-6
• Molecular Formula: C6H11NO3
• Molecular Weight: 145.16
• Product Categories: CARBOXYLICACID
• Mol File: 189385-64-6.mol

Chemical Properties

• Melting Point: 255-275 °C (decomp)
• Boiling Point: 346.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.299±0.06 g/cm3(Predicted)
• PKA: 2.28±0.40(Predicted)
• CAS DataBase Reference: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4R)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4R)-(9CI)(189385-64-6)
• EPA Substance Registry System: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4R)-(9CI)(189385-64-6)

Safety Data

• Hazardous Substances Data: 189385-64-6(Hazardous Substances Data)

Upstream product

• 326477-58-1 (2S,4S)-(-)-4-Acetoxy-2-phenyl-1-trifluoroacetylpiperidine 
• 78553-51-2 (S)-2-(benzyloxycarbonylamino)pent-4-enoic acid 
• 475504-28-0 4-formyloxy-(S)-pipecolic acid methyl ester 
• 1103929-08-3 methyl (2S,4S)-4-hydroxypiperidine-2-carboxylate 
• 126774-16-1 cis-4-hydroxy-1,2-piperidinedicarboxylic acid 1-ethyl, 2-methyl ester 
• 126774-13-8 acetoxyacetic acid methyl ester 
• 135690-64-1 (But-3-enyl-ethoxycarbonyl-amino)-hydroxy-acetic acid methyl ester 
• 1212688-40-8 Boc-4-hydroxypipecolic acid 
• 135690-69-6 trans-4-formyloxy-1,2-piperidinedicarboxylic acid 1-ethyl, 2-methyl ester 
• 326477-51-4 (2R,4R)-(+)-4-Acetoxy-2-phenyl-1-trifluoroacetylpiperidine 
• 1357348-22-1 C₁₅H₁₉NO₅ 
• 1057111-70-2 C₁₄H₁₁BrF₆N₂O₄ 
• 70614-56-1 N-benzyloxycarbonyl-(2S,4R)-4-hydroxypipecolic acid 
• 4382-31-4 (2S,4S)-4-hydroxy-2-piperidinecarboxylic acid 

Downstream Products

• 98593-76-1 4-Hydroxypipecolinsaeurelactonacetat 
• 98593-76-1 (+)-1-Acetyl-4-hydroxy-D-pipecolinsaeurelacton 
• 1844-40-2 (2S,4R)-4-hydroxypiperidine-2-carboxylic acid 
• 917099-02-6 (2S,4S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-hydroxy-2-piperidinecarboxylic acid 
• 441044-12-8 (2S,4S)-N-Boc-4-hydroxypiperidine-2-carboxylic acid 
• 1212688-40-8 Boc-4-hydroxypipecolic acid 
• 441044-14-0 (2S,4S)-N-Boc-4-hydroxypiperidine-2-carboxylic acid benzylamine salt 
• 441044-11-7 (4R)-1-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxylic acid 
• 441044-14-0 phenylmethanaminium (2R,4R)-1-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxylate 
• 917099-02-6 (2S,4R)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-hydroxy-2-piperidinecarboxylic acid 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

TUBULYSIN ANALOGUES AS ANTICANCER AGENTS AND PAYLOADS FOR ANTIBODY-DRUG CONJUGATES AND METHODS OF TREATMENT THEREWITH

In one aspect, the present disclosure provides tubulysin analogs of the formula (I) wherein the variables are as defined herein. In another aspect, the present disclosure also provides methods of preparing the compounds disclosed herein. In another aspect

Improved Total Synthesis of Tubulysins and Design, Synthesis, and Biological Evaluation of New Tubulysins with Highly Potent Cytotoxicities against Cancer Cells as Potential Payloads for Antibody-Drug Conjugates

Improved, streamlined total syntheses of natural tubulysins such as V (Tb45) and U (Tb46) and pretubulysin D (PTb-D43), and their application to the synthesis of designed tubulysin analogues (Tb44, PTb-D42, PTb-D47-PTb-D49, and Tb50-Tb120), are described.

2-Keto-3-Deoxy-l-Rhamnonate Aldolase (YfaU) as Catalyst in Aldol Additions of Pyruvate to Amino Aldehyde Derivatives

4-Hydroxy-2-keto acid derivatives are versatile building blocks for the synthesis of amino acids, hydroxy carboxylic acids and chiral aldehydes. Pyruvate aldolases are privileged catalysts for a straightforward access to this class of keto acid compounds. In this work, a Class II pyruvate aldolase from Escherichia coli K-12, 2-keto-3-deoxy-l-rhamnonate aldolase (YfaU), was evaluated for the synthesis of amino acid derivatives of proline, pipecolic acid, and pyrrolizidine-3-carboxylic acid. The aldol addition of pyruvate to N-protected amino aldehydes was the key enzymatic aldol addition step followed by catalytic intramolecular reductive amination. The corresponding N-Cbz-amino-4-hydroxy-2-keto acid (Cbz=benzyloxycarbonyl) precursors were obtained in 51–95% isolated yields and enantioselectivity ratios from 26:74 to 95:5, with chiral α-substituted N-Cbz-amino aldehydes. (S)-N-Cbz-amino aldehydes gave aldol adducts with preferentially (R)-configuration at the newly formed stereocenter, whereas the contrary is true for (R)-N-Cbz-amino aldehydes. Addition reactions to achiral amino aldehydes rendered racemic aldol adducts. Molecular models of the pre-reaction ternary complexes YfaU-pyruvate enolate-acceptor aldehyde were constructed to explain the observed stereochemical outcome of the reactions. Catalytic reductive amination of the aldol adducts yielded 4-hydroxy-2-pipecolic acid, and unprecedented C-5 substituted 4-hydroxyproline and pyrrolizidine-3-carboxylic acid derivatives. (Figure presented.).

AN ENANTIOSELECTIVE PROCESS FOR THE SYNTHESIS OF (2S,4R)-4-HYDROXYPIPECOLIC ACID

The present invention relates to an improved process for synthesis of 4-hydroxy pipecolic acid. The present invention relates to an improved enantioselective process for the synthesis of (2S,4R)-4-hydroxypipecolic acid via Co(III) (salen)-catalyzed two stereocentered Hydrolytic Kinetic Resolution (HKR) of racemic 1,3-azido epoxide with good yields and high optical purity without any protecting groups. 10 31

Betaines and related ammonium compounds in chestnut (Castanea sativa Mill.)

Chestnut fruits, being poor of simple sugars and consisting mainly of fibers and starch, are among the constituents of Mediterranean diet. While numerous studies report on content of proteins and amino acids in chestnut, no one has appeared so far on betaines, an important class of nitrogen compounds ubiquitous in plants for their protective action in response to abiotic stress. In this study, we analyzed by HPLC-ESI-tandem mass spectrometry, in fruits and flours of varieties of chestnut cultivated in Italy, the composition of betaines and ammonium compounds intermediates of their biosynthesis. Besides the parent amino acids, the compounds quantified were choline, glycerophosphocholine, phosphocholine, glycine betaine, N-methylproline, proline betaine (stachydrine), β-alanine betaine, 4-guanidinobutyric acid, trigonelline, N,N,N-trimethyllysine. Interestingly, some uncommon derivatives of pipecolic acid, such as N-methylpipecolic acid, 4-hydroxypipecolic acid and 4-hydroxy-N-methylpipecolic acid were identified for the first time in chestnut samples and characterized by MSn tandem mass spectrometry.

Ulleungamides A and B, Modified α,β-Dehydropipecolic Acid Containing Cyclic Depsipeptides from Streptomyces sp. KCB13F003

Two novel cyclic depsipeptides, ulleungamides A (1) and B (2), were isolated from cultures of terrestrial Streptomyces sp. Their structures were determined by analyses of spectroscopic data and various chemical transformations, including modified Mosher's method, advanced Marfey's method, PGME, GITC derivatizations, and Snatzke's method. Ulleungamides were determined to be a new class of peptides bearing unprecedented units, such as 5-hydroxy-6-methyl-2,3-dehydropipecolic acid, 4,5-dihydroxy-6-methyl-2,3-dehydropipecolic acid, and amino-linked 2-isopropylsuccinic acid. Ulleungamide A displayed growth inhibitory activity against Staphylococcus aureus and Salmonella typhimurium without cytotoxicity.

Substrate specificity and stereoselectivity of two Sulfolobus 2-keto-3-deoxygluconate aldolases towards azido-substituted aldehydes

The 2-keto-3-deoxygluconate aldolases (KDGAs) isolated from Sulfolobus species convert pyruvate and glyceraldehyde reversibly into 2-keto-3-deoxygluconate and -galactonate. As a result of their high thermostability and activity on nonphosphorylated substrates, KDGA enzymes have potential as biocatalysts for the production of building blocks for fine chemical and pharmaceutical applications. Up to now, wild-type enzymes have only shown moderate stereocontrol for their natural reaction. However, if a set of azido-functionalized aldehydes were applied as alternative acceptors in the reaction with pyruvate, the stereoselectivity was strongly increased to give enantiomeric or diastereomeric excess values up to 97 %. The Sulfolobus acidocaldarius KDGA displayed a higher stereoselectivity than Sulfolobus solfataricus KDGA for all tested reactions. The azido-containing products are useful chiral intermediates in the synthesis of nitrogen heterocycles. Taming the wild-type: Two 2-keto-3-deoxygluconate aldolases from Sulfolobus species readily couple azido-substituted aldehydes to pyruvate in a stereoselective manner. The resulting compounds yield chiral nitrogen heterocycles upon reduction.

A concise and diastereoselective synthesis of piperidine and indolizidine alkaloids via aza-Prins cyclization

The synthesis of 2-substituted and 2,4-disubstituted piperidine alkaloids such as (±)-coniine, (±)-hydroxypipecolic acid, (±)-pipecolic acid, (±)-coniceine, and (±)-4-hydroxy-2- hydroxy-methyl piperidine have been accomplished in a highly diastereo-selective manner by employing aza-Prins cyclization as a key step to construct the piperidine core of these alkaloids. Georg Thieme Verlag Stuttgart · New York.

Validation of high-affinity binding sites for succinic acid through distinguishable binding of gamma-hydroxybutyric acid receptor-specific NCS 382 antipodes

Gamma-hydroxybutyric acid (GHB) binding to multiple sites for the tricarboxylic acid cycle intermediate succinic acid (SUC) has been disclosed recently. In order to better characterize these targets, distinguishable binding of GHB receptor-specific NCS 38